Selegiline (HCl)
Selegiline (HCl) is a selective inhibitor of monoamine oxidase B. Selegiline (HCl) is used along with levodopa in the management of Parkinson's disease. It inhibits the breakdown of dopamine in the brain and prolongs the action of Levodopa
Primary Characteristics
It is of Synthetic origin and belongs to Phenethylamine.
It is classified in Antiparkinson Agents pharmacological group.
Molecular Weight: 223.7 · pKa: 6.88 · Solubility in Water: 1 in 3 · Solubility in Alcohol: 1 in 3 · Non-proprietary name: Selegiline (HCl).

Pharmacokinetics
Absorption: Selegiline (HCl) has an oral bioavailability is 100%.
Distribution: Selegiline (HCl) has a volume of distribution is 4.7 l/kg. plasma protein binding is 94 %.
Elimination: plasma half-life is 9 min, renal excretion is 75 %.
Advertisement
Indications
Selegiline (HCl) is primarily indicated in conditions like Parkinsonism, Parkinson's disease, Parkinson's disease or symptomatic parkinsonism.
Contraindications
Selegiline (HCl) is contraindicated in conditions like Psychosis, Extrapyramidal disorders, Tardive dyskinesias, Huntington's disease.
Dosage
Selegiline (HCl)'s dosage details are as follows:
| Dose | Single Dose | Frequency | Route | Instructions |
|---|---|---|---|---|
| Adult Dosage | ||||
| 7.5 mg | 7.5 mg | Every 24h | PO | |
| Paediatric Dosage (20kg) | ||||
| 0 – 0 | — | — | Not applicable in paeds | |
| Neonatal Dosage (3kg) | ||||
| 0 – 0 | — | — | Not applicable in this age group | |
Drug Interactions
Always consult your physician for the change of dose regimen or an alternative drug of choice that may strictly be required.
Side Effects
Selegiline (HCl) is known to cause more or less tolerable side effects which are usually transient. These include Abdominal pain, Anemia, Confusion, Diarrhea, Dizziness, Dyskinesia , Malaise, Nausea, Palpitation, Urinary retention, Weight loss.
Warnings / Precautions
Available Brands
Click on a strength to view available brands.
Single Ingredient
Storage Conditions
Drug Classification
- 1.9.1 — Drugs used in parkinsonism